Barclays initiated coverage of West Pharmaceutical Services with an equalweight rating on June 24, 2025.
1 report, 0 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays initiated coverage of West Pharmaceutical Services with an equalweight rating on June 24, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
-
West Pharmaceutical Services (United States)
American healthcare company
Nothing else this week.
Related events
- Multiple financial firms (Barclays, UBS, Morgan Stanley, Jefferies) issued rating and price target updates for Equity Lifestyle Properties.
- Barclays, Citigroup, and Raymond James Financial issued rating updates for Alaska Airlines Group on October 23, 2026.
- Barclays adjusted its price target for Labcorp on June 24, 2025.
- Barclays analysts initiated coverage on SpaceX and Palantir Technologies on October 13, 2026.
- On July 11, 2025, a rating action was taken on Hewlett Packard Enterprise and Barclays, including raising the price target and maintaining an overweight rating.
Coverage
Newest first; wire copies grouped- Unknown outlet